Policy | June 26, 2024
CCRAS hosts national consultative meet on traditional medicine
Signs MoUs with Shri Krishna Ayush University and Dabur India
Signs MoUs with Shri Krishna Ayush University and Dabur India
Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months vs. standard of care
First immunotherapy regimen before and after surgery to extend survival in bladder cancer
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
Combined entity is better positioned to compete in increasingly competitive generics industry
The facility was inspected from May 7 to May 17, 2024
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
_256_384.jpg)
The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Subscribe To Our Newsletter & Stay Updated
